Abstract
We report here the first case report of bone marrow transplantation (BMT)-related transmission of human T lymphotropic virus type-I (HTLV-I). Antibodies against HTLV-I-associated antigens (anti-HTLV-I) were detected in the serum from the BMT recipient 12 days post BMT. IgG against gag core proteins (anti-p19 and anti-p24) appeared earlier than IgM against gag and env proteins (anti-p19, anti-p24 and anti-gp46) during seroconversion. The data presented here differs from blood transfusion-related seroconversion. This phenomenon may be due to the engraftment of anti-HTLV-I producing cells from the donor. Bone Marrow Transplantation (2000) 26, 1235–1237.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Okochi K, Sato H, Hinuma Y . A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients Vox Sang 1984 46: 245–253
Miyoshi I, Kubonishi I, Yoshimoto S et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T-cells Nature 1981 294: 770–771
Manns A, Wilks RJ, Murphy EL et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversions Int J Cancer 1992 51: 886–891
Kamihira S, Sohda H, Monita S et al. IgM anti-ATLA antibodies in HTLV-I healthy carriers and patients with adult T-cell leukemia and HTLV-I associated myelopathy J Jpn Soc Intern Med 1988 77: 481–486
Kawa K, Nishiuchi R, Okamura T et al. Eradication of human T-lymphotropic virus type I by allogeneic bone-marrow transplantation Lancet 1998 352: 1034–1035
Kanda Y, Taketazu F, Chiba S et al. Persistent infection with human T lymphotropic virus type I after allogeneic bone marrow transplantation from a seronegative donor Bone Marrow Transplant 1999 24: 349
Ljungman P, Lawler M, Asjo R et al. Infection of donor lymphocytes with human T lymphotropic virus type I (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia Br J Haematol 1994 88: 403–405
Chen YC, Wang CH, Su IJ et al. Infection of human T-cell leukemia virus type-I and development of human T-cell leukemia/lymphoma in patients with hematologic neoplasm: a possible linkage to blood transfusion Blood 1989 74: 388–394
Gout O, Baulac M, Gessain A et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation New Engl J Med 1990 322: 383–388
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kikuchi, H., Ohtsuka, E., Ono, K. et al. Allogeneic bone marrow transplantation-related transmission of human T lymphotropic virus type I (HTLV-I). Bone Marrow Transplant 26, 1235–1237 (2000). https://doi.org/10.1038/sj.bmt.1702698
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702698
Keywords
This article is cited by
-
Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee
Bone Marrow Transplantation (2014)
-
Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision
Bone Marrow Transplantation (2013)
-
Hematopoietic stem cells and retroviral infection
Retrovirology (2010)